Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Biotechnology

Healthcare
$4.16 +2.94%

+$0.14 today

Market cap
$120.02M
Beta
0.29
P/E (TTM)
-3.0
EPS (TTM)
-$1.66
52W Low $3.20High $12.99

Volume 0.27M

Average 0.08M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$20.36M

FY 2025 · Annual

Investing Cash Flow

-$500,000.00

FY 2025 · Annual

Financing Cash Flow

$20.86M

FY 2025 · Annual

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$62.1M
+ D&A$36.5K
+ Stock-Based Comp$35.6M
+ Deferred Tax$0
+ Working Capital$2.1M
+ Other Non-Cash$4.1M
= Operating Cash Flow-$20.4M
- Capex-$500.0K
= Free Cash Flow-$20.9M

Analysis

FY2025 free cash flow is -$20.9M. FCF conversion is 33.6% of net income. Operating cash flow was -$20.4M, with capex of -$500.0K. The largest bridge item is Stock-Based Comp at $35.6M.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 9, 2026

Does NTHI generate free cash flow?

Neonc Technologies Holdings, Inc. (NTHI) generated -$20.86M of free cash flow in fiscal 2025.

How much operating cash flow does NTHI produce?

Operating cash flow was -$20.36M, before capital expenditures of $500,000.00.